Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Dr. Reddy's Laboratories Limited
  6. Summary
    500124   INE089A01023

DR. REDDY'S LABORATORIES LIMITED

(500124)
  Report
End-of-day quote. End-of-day quote Bombay Stock Exchange - 06/15
5414.9 INR   -0.82%
06/14Asian ADRs Barely Higher Monday Morning; Quidan, Aslan Pharma Surge
MT
06/11Asian ADRs Move Lower in Friday Trading
MT
06/10Asian ADRs Move Higher in Thursday Trading
MT
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bombay Stock Exchange
06/09/2021 06/10/2021 06/11/2021 06/14/2021 06/15/2021 Date
5221.85 5290.65 5451.2 5459.55 5414.9 Last
24125 20314 63576 37783 196755 Volume
-1.00% +1.32% +3.03% +0.15% -0.82% Change
Financials
Sales 2021 191 B 2 603 M 2 603 M
Net income 2021 22 584 M 308 M 308 M
Net cash position 2021 10 733 M 146 M 146 M
P/E ratio 2021 37,9x
Yield 2021 0,45%
Sales 2022 232 B 3 166 M 3 166 M
Net income 2022 32 991 M 450 M 450 M
Net cash position 2022 25 092 M 342 M 342 M
P/E ratio 2022 27,4x
Yield 2022 0,52%
Capitalization 898 B 12 236 M 12 235 M
EV / Sales 2021 4,64x
EV / Sales 2022 3,76x
Nbr of Employees 21 650
Free-Float 66,7%
More Financials
Company
Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows: - sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines; - sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services; - other (4.4%): sales of generic biopharmaceutical products,... 
More about the company
Ratings of Dr. Reddy's Laboratories Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about DR. REDDY'S LABORATORIES LIMITED
06/14Asian ADRs Barely Higher Monday Morning; Quidan, Aslan Pharma Surge
MT
06/11Asian ADRs Move Lower in Friday Trading
MT
06/10Asian ADRs Move Higher in Thursday Trading
MT
06/09DR REDDY LABORATORIESá : Partners with Rockwell Industries for COVID-19 Vaccine ..
MT
06/07DR REDDY LABORATORIESá : . Reddy's Recalls Atorvastatin Calcium Bottles in US ov..
MT
06/04SUB : Allotment of Equity Shares on exercise of ESOP (Form 6-K)
PU
06/03Snowman Logistics Partners with Dr. Reddy's Laboratories for Delivery of COVI..
MT
06/02Asian ADRs Slightly Lower in Wednesday Trading
MT
06/01Asian ADRs Climb Higher in Tuesday Trading
MT
05/26Asian ADRs Move Higher Wednesday Amid Gains by Techs
MT
05/26DR REDDY LABORATORIESá : Delhi High Court Dismisses An Injunction Application Fi..
AQ
05/25Asian ADRs Move Higher in Tuesday Trading
MT
05/25DR REDDY LABORATORIESá : Plans $137 Million Capex for FY22
MT
05/24TELá : +91 40 4900 2900 Faxá:+91 40 4900 2999 (Form 6-K)
PU
05/21Asian ADRs Move Lower in Friday Trading
MT
More news
News in other languages on DR. REDDY'S LABORATORIES LIMITED
04/27Merck ermöglicht indischen Generikaherstellern Zugang zu Covid-19-Kandidaten
04/12DR REDDY LABORATORIESá : Coronavirus-L'Inde approuve le vaccin russe Sputnik V
2019INDIVIORá : paie cher sa dépendance au Subutex
More news
Analyst Recommendations on DR. REDDY'S LABORATORIES LIMITED
More recommendations
Chart DR. REDDY'S LABORATORIES LIMITED
Duration : Period :
Dr. Reddy's Laboratories Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DR. REDDY'S LABORATORIES LIMITED
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 33
Average target price 5 670,06 INR
Last Close Price 5 414,90 INR
Spread / Highest target 18,2%
Spread / Average Target 4,71%
Spread / Lowest Target -20,6%
EPS Revisions
Managers and Directors
NameTitle
Erez Israeli Chief Executive & Operating Officer
Parag Agarwal Chief Financial Officer
Satish Kallam Reddy Co-Chairman
Gunupati Venkateswara Prasad Co-Chairman & Managing Director
Sandeep Poddar Secretary & Compliance Officer
Sector and Competitors
1st jan.Capitalization (M$)
DR. REDDY'S LABORATORIES LIMITED4.05%12 236
JOHNSON & JOHNSON4.52%433 167
ROCHE HOLDING AG11.21%330 710
PFIZER, INC.7.55%221 613
NOVARTIS AG0.77%210 689
ABBVIE INC.8.10%204 582